Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.

Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.

SARAUX A, COMBE B, FAGNANI F, CUKIERMAN G, BRU I, JOUBERT J.-M , SCHULLER J.-C, MASSOL J, FLIPO R.-M